Letter to the Editor
Leukemia (2008) 22, 1273–1274; doi:10.1038/sj.leu.2405029; published online 8 November 2007
Treatment of relapsed acute myeloid leukemia with MLL/AF6 fusion after allogeneic hematopoietic stem cell transplantation with gemtuzumab ozogamicin with a long interval followed by donor lymphocyte infusion
H Tamai1,2, Y Shioi1,2, H Yamaguchi1, M Okabe1, S Wakita1, T Mizuki1, K Nakayama1, K Inokuchi1, K Tajika1 and K Dan1
1Department of Hematology, Nippon Medical School, Tokyo, Japan
Correspondence: H Tamai, E-mail: s6056@nms.ac.jp
2These two authors contributed equally to this work.
Top of page
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
